ArticlePediatric cardiology2026
Lung Density Measurement in Fontan Patients Using Zero Echo Time Sequences.
Article in Pediatric cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pulmonary complications are known to occur in patients after Fontan palliation. Cardiac MRI is performed in the follow-up of Fontan patients to assess single ventricular function, hemodynamics and potential collateral flow. To date, pulmonary function tests have been used to detect functional lung impairment, but lung MRI has not been integrated into imaging follow-up. In this study, we measured lung-to-background ratio (LBR) on zero echo time (ZTE) MRI sequences in 32 children with Fontan palliation. Patients were divided into 2 groups: LBR > 1.5 and < 1.5 and assessed for associations between LBR and ventricular function, fibrosis, hemodynamics as well as biomarkers, spirometry and previous catheter results. We observed significantly increased extracellular volume (ECV) and decreased tissue inhibitor of metalloproteinase 1 (TIMP-1), soluble suppression of tumorigenicity 2 (sST-2) and a trend towards decreased growth differentiation factor 15 (GDF-15) as well as decreased albumin and prothrombin time values in patients with elevated LBR, whereas the other cardiovascular and pulmonary parameters did not differ significantly. Moreover, patients with LBR > 1.5 had a history of increased pulmonary arterial pressure prior to the Fontan and Glenn procedures and interventional veno-venous collateral embolization. Monitoring lung density with ZTE MRI sequences may be helpful in the diagnostic workup to assess the outcome of patients after Fontan procedure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.